Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.71 USD | -4.56% | -16.60% | -37.71% |
22/05 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
07/05 | Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.71% | 934M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.67% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Transcript : Scholar Rock Holding Corporation Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 09